Accedi

Bibliografie tematiche / Small Cell Lung Cancer / Articoli di riviste

Segui questo link per vedere altri tipi di pubblicazioni sul tema: Small Cell Lung Cancer.

Articoli di riviste sul tema "Small Cell Lung Cancer"

Autore: Grafiati

Pubblicato: 4 giugno 2021

Ultima modifica: 25 luglio 2025

Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili

Scegli il tipo di fonte:

Vedi i top-50 articoli di riviste per l'attività di ricerca sul tema "Small Cell Lung Cancer".

Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.

Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.

Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.

1

Greschuchna, D. "Surgical Treatment of Small Cell Lung Cancer." Journal of the Japanese Association for Chest Surgery 3, no. 2 (1989): 169. http://dx.doi.org/10.2995/jacsurg1987.3.2_169.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

2

Skenduli, Ilir, and Perlat Kapisyzi. "Surgery for Non Small Cell Lung Cancer - A Systematic Review." International Journal of Science and Research (IJSR) 11, no. 5 (2022): 1551–56. http://dx.doi.org/10.21275/sr22518021202.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

3

_, _. "Small Cell Lung Cancer." Journal of the National Comprehensive Cancer Network 6, no. 3 (2008): 294. http://dx.doi.org/10.6004/jnccn.2008.0025.

Testo completo

Abstract (sommario):

Small cell lung cancer (SCLC) accounts for 15% of lung cancers. Nearly all cases of SCLC are attributable to cigarette smoking, and the remaining cases are presumably caused by environmental or genetic factors. Compared with non-small cell lung cancer, SCLC generally has a more rapid doubling time, a higher growth fraction, and earlier development of widespread metastases. SCLC is highly sensitive to initial chemotherapy and radiotherapy, but most patients eventually die from recurrent disease. These guidelines detail the management of SCLC from initial diagnosis and staging through treatment,

Gli stili APA, Harvard, Vancouver, ISO e altri

4

Hellriegel, H. "ADVANCED NON-SMALL-CELL LUNG CANCER. THE SIGNIFICANCE OF PERSONALIZED THERAPY." Siberian Medical Review, no. 6 (2017): 6–12. http://dx.doi.org/10.20333/2500136-2017-6-12.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

5

Klaus-Peter, K. "ADVANCED NON-SMALL-CELL LUNG CANCER. THE SIGNIFICANCE OF PERSONALIZED THERAPY." Siberian Medical Review, no. 6 (2017): 6–12. http://dx.doi.org/10.20333/2500136-2017-6-6-12.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

6

Kammaev, K. A. "Non-small cell lung carcinoma. Clinical case." Filin’s Clinical endoscopy 66, no. 3 (2024): 62–65. http://dx.doi.org/10.31146/2415-7813-endo-66-3-62-65.

Testo completo

Abstract (sommario):

In 2020, 2.2 million new cases of lung cancer were reported. The main form of lung cancer is non-small cell carcinoma (85%). Non-small cell lung cancer has 3 subtypes: adenocarcinoma, large cell and squamous cell carcinoma. Squamous cell lung cancer occurs in 20-40% of all lung cancers. Squamous cell lung cancer is associated with an unfavorable outcome. 5-year survival rate not exceeding 18%.

Gli stili APA, Harvard, Vancouver, ISO e altri

7

Kalemkerian, Gregory P., Wallace Akerley, Paul Bogner, et al. "Small Cell Lung Cancer." Journal of the National Comprehensive Cancer Network 9, no. 10 (2011): 1086–113. http://dx.doi.org/10.6004/jnccn.2011.0092.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

8

Kalemkerian, Gregory P., Wallace Akerley, Paul Bogner, et al. "Small Cell Lung Cancer." Journal of the National Comprehensive Cancer Network 11, no. 1 (2013): 78–98. http://dx.doi.org/10.6004/jnccn.2013.0011.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

9

Byrne, Bernadette. "Small cell lung cancer." Nursing Standard 8, no. 9 (1993): 23–28. http://dx.doi.org/10.7748/ns.8.9.23.s42.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

10

Hinson, J. A., and M. C. Perry. "Small cell lung cancer." CA: A Cancer Journal for Clinicians 43, no. 4 (1993): 216–25. http://dx.doi.org/10.3322/canjclin.43.4.216.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

11

Bakhmutsky, Nicolay G., Vladimir A. Porkhanov, Vadim N. Bodnya, and Rostislav P. Schiryayev. "Small-cell lung cancer." Medical Herald of the South of Russia 8, no. 4 (2017): 6–13. http://dx.doi.org/10.21886/2219-8075-2017-8-4-6-13.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

12

Sher, Taimur, Grace K. Dy, and Alex A. Adjei. "Small Cell Lung Cancer." Mayo Clinic Proceedings 83, no. 3 (2008): 355–67. http://dx.doi.org/10.4065/83.3.355.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

13

&NA;. "Small-Cell Lung Cancer." Oncology Times 26, no. 19 (2004): 23. http://dx.doi.org/10.1097/01.cot.0000292340.59988.2c.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

14

McVie, J. G., O. B. Dalesio, and H. van Tinteren. "Small Cell Lung Cancer." Acta Oncologica 28, no. 5 (1989): 729–41. http://dx.doi.org/10.3109/02841868909092304.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

15

Crompton, G. "Small cell lung cancer." BMJ 300, no. 6719 (1990): 209–10. http://dx.doi.org/10.1136/bmj.300.6719.209.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

16

Sheppard, M. N. "Small cell lung cancer." BMJ 300, no. 6723 (1990): 535. http://dx.doi.org/10.1136/bmj.300.6723.535-b.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

17

Rosti, G., G. Bevilacqua, P. Bidoli, L. Portalone, A. Santo, and G. Genestreti. "Small cell lung cancer." Annals of Oncology 17 (April 2006): ii5—ii10. http://dx.doi.org/10.1093/annonc/mdj910.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

18

&NA;. "Small cell lung cancer." Inpharma Weekly &NA;, no. 838 (1992): 10. http://dx.doi.org/10.2165/00128413-199208380-00015.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

19

Haque, Niaz, Amer Raza, Robin McGoey, Brian Boulmay, Lisa Diethelm, and Stephen Kantrow. "Small Cell Lung Cancer." Southern Medical Journal 105, no. 8 (2012): 418–23. http://dx.doi.org/10.1097/smj.0b013e3182601198.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

20

Eisen, Tim, Tamas Hickish, I. E. Smith, John Sloane, and Suzanne Eccles. "Small-cell lung cancer." Lancet 345, no. 8960 (1995): 1285–89. http://dx.doi.org/10.1016/s0140-6736(95)90930-3.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

21

Simon, George R., and Henry Wagner. "Small Cell Lung Cancer*." Chest 123, no. 1 (2003): 259S—271S. http://dx.doi.org/10.1378/chest.123.1_suppl.259s.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

22

Postmus, Pieter E. "Small-cell lung cancer." Lung Cancer 77 (June 2012): S19—S20. http://dx.doi.org/10.1016/j.lungcan.2012.05.098.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

23

Berendsen, H. H., L. de Leij, P. E. Postmus, et al. "Small Cell Lung Cancer." Chest 91, no. 3 (1987): 11s—12s. http://dx.doi.org/10.1378/chest.91.3_supplement.11s.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

24

Ihde, D., B. Souhami, R. Comis, et al. "Small cell lung cancer." Lung Cancer 17 (June 1997): S19—S21. http://dx.doi.org/10.1016/s0169-5002(97)00039-1.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

25

Jackman, David M., and Bruce E. Johnson. "Small-cell lung cancer." Lancet 366, no. 9494 (2005): 1385–96. http://dx.doi.org/10.1016/s0140-6736(05)67569-1.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

26

Ploner, F. "Small cell lung cancer." memo - Magazine of European Medical Oncology 1, no. 4 (2008): 243–45. http://dx.doi.org/10.1007/s12254-008-0067-5.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

27

Goodman, Gary R., and Robert B. Livingston. "Small cell lung cancer." Disease-a-Month 35, no. 12 (1989): 774–825. http://dx.doi.org/10.1016/0011-5029(89)90023-0.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

28

Livingston, Robert, and Gary E. Goodman. "Small cell lung cancer." Current Problems in Cancer 13, no. 1 (1989): 7–54. http://dx.doi.org/10.1016/0147-0272(89)90014-7.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

29

Leonard, RCF. "Small cell lung cancer." British Journal of Cancer 59, no. 4 (1989): 487–90. http://dx.doi.org/10.1038/bjc.1989.101.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

30

van Meerbeeck, Jan P., Dean A. Fennell, and Dirk KM De Ruysscher. "Small-cell lung cancer." Lancet 378, no. 9804 (2011): 1741–55. http://dx.doi.org/10.1016/s0140-6736(11)60165-7.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

31

Elias, Anthony D. "Small Cell Lung Cancer." Chest 112, no. 4 (1997): 251S—258S. http://dx.doi.org/10.1378/chest.112.4_supplement.251s.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

32

Kalemkerian, Gregory. "Small Cell Lung Cancer." Seminars in Respiratory and Critical Care Medicine 37, no. 05 (2016): 783–96. http://dx.doi.org/10.1055/s-0036-1592116.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

33

O'Donnell, Walter J. "Small Cell Lung Cancer." Chest 107, no. 6 (1995): 241S—242S. http://dx.doi.org/10.1378/chest.107.6_supplement.241s.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

34

Ihde, Daniel C. "Small Cell Lung Cancer." Chest 107, no. 6 (1995): 243S—248S. http://dx.doi.org/10.1378/chest.107.6_supplement.243s.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

35

Simon, George, Robert J. Ginsberg, and John C. Ruckdeschel. "Small-Cell Lung Cancer." Chest Surgery Clinics of North America 11, no. 1 (2001): 165–88. https://doi.org/10.1016/s1052-3359(25)00558-7.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

36

Kurata, Takayasu, Isamu Okamoto, Kenji Tamura, and Masahiro Fukuoka. "Amrubicin for non-small-cell lung cancer and small-cell lung cancer." Investigational New Drugs 25, no. 5 (2007): 499–504. http://dx.doi.org/10.1007/s10637-007-9069-0.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

37

Bhargav, Manjunath Hegde, Ganapati Hegde Mahesh, Channappagol Chetan, and P. Dayananda. "Review on Deep Learning Technique for Detecting Non-Small Cell Lung Cancer." Journal of Information Technology and Sciences 5, no. 3 (2019): 15–20. https://doi.org/10.5281/zenodo.3377126.

Testo completo

Abstract (sommario):

<em>The lung cancer is one of the major cancers in the world. Almost 80% of cancer we found in the world is related to lung only. We can find two different lung cancers; there are small cell lung cancer and non-small cell lung cancer. Here, we are only concentrated about the non-small cell lung cancer or (NSCLC). Here, we considered the KRAS mutation of the human gene. The KRAS biomarker is one of the main reasons for the NSCLC. Nearly 25% of the mutations happen in the form of KRAS mutation. Here, we have reviewed different deep learning and machine learning methods like convolutional neural

Gli stili APA, Harvard, Vancouver, ISO e altri

38

Sankar, V., R. Kothai, and N. Vanisr. "Lung Cancer - A Review." International Journal of Health Sciences and Research 13, no. 10 (2023): 307–15. http://dx.doi.org/10.52403/ijhsr.20231042.

Testo completo

Abstract (sommario):

Lung cancer is the prime cause of cancer death among both men and women according to WHO report 2.09 million cases globally. It is also the chief cause of cancer death among men and the second leading cause of cancer death among women worldwide. The lung cancer classified into two different types are small-cell lung cancers (SCLC) and non-small-cell lung cancers (NSCLC). Non-small cell lung cancer is more common than small cell lung cancer. Treatment of lung cancer may involve a combination of surgery, chemotherapy, targeted therapy, immunotherapy, and radiation therapy. Therapeutic recommenda

Gli stili APA, Harvard, Vancouver, ISO e altri

39

Kalkan, Fatih, and Mehmet Özler. "DELTA-9 TETRAHYDROCANNABINOID AND GEMSITABIN COMBINATION ON NON-SMALL CELL (SQUAMOUS CELL, SK-MES-1) LUNG CANCER CELL LINE." Era's Journal of Medical Research 10, no. 01 (2023): 1–12. http://dx.doi.org/10.24041/ejmr2023.1.

Testo completo

Abstract (sommario):

Squamous cell carcinoma falls within the category of non-small cell lung cancers, presenting a considerable challenge in terms of treatment management. There has been growing interest in the potential anti-cancer properties of Delta-9 tetrahydrocannabinol. Gemcitabine, a nucleoside analog, has shown effectiveness against diverse cancer types. This study aimed to assess the combined efficacy of Delta-9 tetrahydrocannabinol and Gemcitabine in treating cancer. The squamous lung cancer cell line required for our study was provided by the stem cell unit. The doses were determined as 5µm/L and 10µm/

Gli stili APA, Harvard, Vancouver, ISO e altri

40

Nakanishi, Yoichi. "Chemotherapy for Lung Cancer (Small-cell Lung Cancer)." Haigan 56, no. 1 (2016): 43–47. http://dx.doi.org/10.2482/haigan.56.43.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

41

_, _. "Non–Small Cell Lung Cancer." Journal of the National Comprehensive Cancer Network 6, no. 3 (2008): 228. http://dx.doi.org/10.6004/jnccn.2008.0021.

Testo completo

Abstract (sommario):

Lung cancer is the leading cause of cancer-related death in both men and women in the United States. An estimated 213,380 new cases (114,760 men and 98,620 women) of lung and bronchus cancer will be diagnosed in 2007, and 160,390 deaths (89,510 in men, 70,880 in women) are estimated to occur because of the disease. Non-small cell lung cancer (NSCLC) accounts for 80% to 85% of all lung cancer cases and includes 3 major types: (1) adenocarcinoma; (2) squamous cell (epidermoid) carcinoma; and (3) large-cell carcinoma. Adenocarcinoma is the most common type of lung cancer seen in the United States

Gli stili APA, Harvard, Vancouver, ISO e altri

42

End, A. "Diagnosis and treatment of lung cancer – Non-small cell lung cancer, small cell lung cancer and carcinoids." European Surgery 38, no. 1 (2006): 45–53. http://dx.doi.org/10.1007/s10353-006-0209-0.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

43

Ross, Mitchell D., Sreeja Biswas Roy, Pradnya D. Patil, et al. "Coexistent Non–Small Cell Carcinoma and Small Cell Carcinoma in a Patient Presenting with Hyponatremia." Case Reports in Pulmonology 2018 (2018): 1–4. http://dx.doi.org/10.1155/2018/1718326.

Testo completo

Abstract (sommario):

Despite recent advances in screening methods, lung cancer remains the leading cause of cancer-related deaths worldwide. By the time lung cancer becomes symptomatic and patients seek treatment, it is often too advanced for curative measures. Low-dose computed tomography (CT) screening has been shown to reduce mortality in patients at high risk of lung cancer. We present a 66-year-old man with a 50-pack-year smoking history who had a right upper lobe (RUL) pulmonary nodule and left lower lobe (LLL) consolidation on a screening CT. He reported a weight loss of 45 pounds over 3 months, had recentl

Gli stili APA, Harvard, Vancouver, ISO e altri

44

Deniz, Özdemir. "KAN0438757: A NOVEL PFKFB3 INHIBITOR THAT INDUCES PROGRAMMED CELL DEATH AND SUPPRESSES CELL MIGRATION IN NON-SMALL CELL LUNG CARCINOMA CELLS." Biotechnologia Acta 16, no. 5 (2023): 34–44. http://dx.doi.org/10.15407/biotech16.05.034.

Testo completo

Abstract (sommario):

Aim. PFKFB3 is glycolytic activators that is overexpressed in human lung cancer and plays a crucial role in multiple cellular functions including programmed cell death. Despite the many small molecules described as PFKFB3 inhibitors, some of them have shown disappointing results in vitro and in vivo. On the other hand KAN0438757, selective and potent, small molecule inhibitor has been developed. However, the effects of KAN0438757, in non-small cell lung carcinoma cells remain unknown. Herein, we sought to decipher the effect of KAN0438757 on proliferation, migration, DNA damage, and programmed

Gli stili APA, Harvard, Vancouver, ISO e altri

45

Skřičková, Jana, Bohdan Kadlec, and Ondřej Venclíček. "Non-small cell lung cancer." Vnitřní lékařství 63, no. 11 (2017): 861–74. http://dx.doi.org/10.36290/vnl.2017.159.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

46

Ettinger, David S., Wallace Akerley, Gerold Bepler, et al. "Non–Small Cell Lung Cancer." Journal of the National Comprehensive Cancer Network 8, no. 7 (2010): 740–801. http://dx.doi.org/10.6004/jnccn.2010.0056.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

47

Ettinger, David S., Wallace Akerley, Hossein Borghaei, et al. "Non–Small Cell Lung Cancer." Journal of the National Comprehensive Cancer Network 10, no. 10 (2012): 1236–71. http://dx.doi.org/10.6004/jnccn.2012.0130.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

48

Susman, Ed. "Advanced Small-Cell Lung Cancer." Oncology Times 36, no. 20 (2014): 26. http://dx.doi.org/10.1097/01.cot.0000456288.49614.66.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

49

Armstrong, J., B. Shank, H. Scher, et al. "Limited Small-Cell Lung Cancer." American Journal of Clinical Oncology 14, no. 4 (1991): 285–90. http://dx.doi.org/10.1097/00000421-199108000-00003.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

50

Von Eyben, F. E. "Treating small cell lung cancer." BMJ 305, no. 6844 (1992): 53. http://dx.doi.org/10.1136/bmj.305.6844.53.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

Offriamo sconti su tutti i piani premium per gli autori le cui opere sono incluse in raccolte letterarie tematiche. Contattaci per ottenere un codice promozionale unico!